Siegmund Gutman

The Seventh Circuit Asks, "What's Wrong With Having Lots Of Patents?"

In The Courtroom: The Importance Of Educating The Judge During Patent & Life Sciences Cases (Video)

"Negative" Patent Claim Limitations—May They Be Adequately Described By Omission?

Skinny Labels May Not Be Dead: Delaware District Court Distinguishes GSK, Dismisses Induced Infringement Claim

Juno V. Kite: Written Description And Claiming Antibodies And Chimeric Antigen Receptors—Lessons For Patent Prosecutors

In The Orphan Drug Approval Race, Winner Takes All? Ramifications Of Catalyst Pharms. V. Becerra

GSK v. Teva: Federal Circuit Issues New Opinion Analyzing Induced Infringement

President Biden's Executive Order On Competition Signals Potential Changes Affecting Patents In The Healthcare Sector

Induced Infringement Of Method Of Treatment Claims: Looking To The Label And Beyond

"Advancing Education On Biosimilars": Game Changer Or More Of The Same?